ClinicalTrials.Veeva

Menu

Auricular Acupressure for Perimenopausal Women With Anxiety (AAA)

C

Chang-Hua Hospital

Status

Unknown

Conditions

Auricular Acupressure
Menopause
Insomnia
Anxiety

Treatments

Other: sham acupressure
Other: auricular acupressure

Study type

Interventional

Funder types

Other

Identifiers

NCT01056458
98DMR291

Details and patient eligibility

About

This study is expected to show auricular acupressure therapy help to improve the anxiety symptoms of perimenopausal and early postmenopausal women, looking forward to developing a convenient, safe and effective way to reduce the use of sedative hypnotics and their dependencies, thereby improving their quality of life.

Full description

There are several stages of women while they were particularly vulnerable to anxiety and insomnia , especially in the pre-menstruation, pregnancy, postpartum, and menopause stage. Sleep problems are common in menopausal and postmenopausal women, its prevalence can be based on research from 15% to 60%. As for anxiety, the prevalence of women in this population can reach 53.7%. Several studies overseas have already pointed out that the improvement of acupuncture for anxiety disorders have had pretty good results. As auricular acupressure with a simple operation and the advantages of non-invasive, our interest is to explore the clinical benefit of combined auricular acupressure and medical therapy on anxiety and insomnia improvement in menopausal and early post-menopausal women. We design a double-blind, randomized controlled study, the subjects are ninety 40 to 60 years old women, during perimenopause and early postmenopause who are accompanied by anxiety symptoms. They were randomly divided into experimental and control groups, use the tape of ear adhesive beads on shenmen and subcortical area of both ears after three meals and before bed for three minutes each area with alternating ears, twice a week to replace paste. A total treatment time is eight times and a total of four weeks. Primary efficacy assessment (primary outcome measure) for the Hamilton Anxiety Rating Scale (HAMA) total score change. Secondary efficacy assessments (secondary outcome measure) for: 1) Menopause Rating Scale (MRS) scores; 2) Short Form Health Survey (SF-36) scores; 3) Clinical Global Impression-Severity (CGI-S) scores; and 4) Clinical Global Impression-Improvement (CGI-I) score changes.

Enrollment

90 estimated patients

Sex

Female

Ages

40 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age between 40 to 60 years
  • irregular menstrual cycle less than 12 months or no menstrual cycle less than 10 years
  • FSH level>= 14 IU/L
  • Brief symptom rating scale total scores>= 6

Exclusion criteria

  • severe medical conditions
  • substance dependence or abuse
  • contraindication of BZDs
  • contraindication of acupressure
  • other primary anxiety disorder and major psychosis
  • use hormone therapy
  • use herb medicine

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Double Blind

90 participants in 2 patient groups

Acupressure acupressure
Active Comparator group
Treatment:
Other: auricular acupressure
sham acupressure
Sham Comparator group
Treatment:
Other: sham acupressure

Trial contacts and locations

1

Loading...

Central trial contact

Ching-Liang Hsieh, MD,PhD; Ching-Ling Kao, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems